Tyrosine kinase inhibitors
    2.
    发明授权
    Tyrosine kinase inhibitors 失效
    酪氨酸激酶抑制剂

    公开(公告)号:US06479512B1

    公开(公告)日:2002-11-12

    申请号:US09690602

    申请日:2000-10-17

    IPC分类号: A61K3147

    CPC分类号: C07D401/04 C07D401/14

    摘要: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.

    摘要翻译: 本发明涉及抑制,调节和/或调节酪氨酸激酶信号转导的化合物,含有这些化合物的组合物及其用于治疗酪氨酸激酶依赖性疾病和病症如血管生成,癌症,肿瘤生长,动脉粥样硬化的方法 ,年龄相关性黄斑变性,糖尿病性视网膜病变,炎症性疾病等。

    Tyrosine kinase inhibitors
    3.
    发明授权
    Tyrosine kinase inhibitors 失效
    酪氨酸激酶抑制剂

    公开(公告)号:US06544988B1

    公开(公告)日:2003-04-08

    申请号:US09914985

    申请日:2001-09-06

    IPC分类号: C07D48704

    摘要: The present invention relates to pyrazolo-pyrimidinyl compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.

    摘要翻译: 本发明涉及抑制,调节和/或调节酪氨酸激酶信号转导的吡唑并嘧啶基化合物,其含有这些化合物的组合物及其用于治疗酪氨酸激酶依赖性疾病和病症如血管生成,癌症,肿瘤的方法 生长,动脉粥样硬化,年龄相关性黄斑变性,糖尿病性视网膜病变,炎症性疾病等。